146 related articles for article (PubMed ID: 31082996)
1. Diagnosis and characterization of malignant effusions through pleural fluid cytological examination.
Porcel JM
Curr Opin Pulm Med; 2019 Jul; 25(4):362-368. PubMed ID: 31082996
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
3. Molecular Testing on Pleural Fluid Samples.
Oh S; Ronaghi R; Cai G
Semin Respir Crit Care Med; 2019 Jun; 40(3):340-346. PubMed ID: 31525809
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
[TBL] [Abstract][Full Text] [Related]
5. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Porcel JM
Ther Adv Respir Dis; 2018; 12():1753466618808660. PubMed ID: 30354850
[TBL] [Abstract][Full Text] [Related]
7. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
[TBL] [Abstract][Full Text] [Related]
8. Cytopathology of pleural mesotheliomas.
Nguyen GK
Am J Clin Pathol; 2000 Nov; 114 Suppl():S68-81. PubMed ID: 11996173
[TBL] [Abstract][Full Text] [Related]
9. Prospective study to determine the volume of pleural fluid required to diagnose malignancy.
Swiderek J; Morcos S; Donthireddy V; Surapaneni R; Jackson-Thompson V; Schultz L; Kini S; Kvale P
Chest; 2010 Jan; 137(1):68-73. PubMed ID: 19741064
[TBL] [Abstract][Full Text] [Related]
10. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
11. Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model.
Porcel JM; Esquerda A; Martínez-Alonso M; Bielsa S; Salud A
Medicine (Baltimore); 2016 Mar; 95(10):e3044. PubMed ID: 26962828
[TBL] [Abstract][Full Text] [Related]
12. The cell block method increases the diagnostic yield in exudative pleural effusions accompanying lung cancer.
Köksal D; Demırağ F; Bayız H; Koyuncu A; Mutluay N; Berktaş B; Berkoğlu M
Turk Patoloji Derg; 2013; 29(3):165-70. PubMed ID: 24022305
[TBL] [Abstract][Full Text] [Related]
13. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
[TBL] [Abstract][Full Text] [Related]
15. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the detection of the homozygous deletion of P16 gene in malignant pleural effusion.
Gui S; Liu H; Zhang L; Zuo L; Zhou Q; Fei G; Wang Y
Intern Med; 2007; 46(15):1161-6. PubMed ID: 17675763
[TBL] [Abstract][Full Text] [Related]
17. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
18. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
19. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
20. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
